Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleDrug Discovery and Translational Medicine

AZD9668: Pharmacological Characterization of a Novel Oral Inhibitor of Neutrophil Elastase

T. Stevens, K. Ekholm, M. Gränse, M. Lindahl, V. Kozma, C. Jungar, T. Ottosson, H. Falk-Håkansson, A. Churg, J. L. Wright, H. Lal and A. Sanfridson
Journal of Pharmacology and Experimental Therapeutics October 2011, 339 (1) 313-320; DOI: https://doi.org/10.1124/jpet.111.182139
T. Stevens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Ekholm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Gränse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Lindahl
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Kozma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Jungar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Ottosson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Falk-Håkansson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Churg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. L. Wright
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Lal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Sanfridson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 339 no. 1 313-320
DOI 
https://doi.org/10.1124/jpet.111.182139
PubMed 
21791628

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received March 31, 2011
  • Accepted July 25, 2011
  • Published online September 19, 2011.

Article Versions

  • Earlier version (July 26, 2011 - 09:58).
  • Earlier version (August 3, 2011 - 06:28).
  • Earlier version (August 5, 2011 - 06:36).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2011 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. T. Stevens,
  2. K. Ekholm,
  3. M. Gränse,
  4. M. Lindahl,
  5. V. Kozma,
  6. C. Jungar,
  7. T. Ottosson,
  8. H. Falk-Håkansson,
  9. A. Churg,
  10. J. L. Wright,
  11. H. Lal and
  12. A. Sanfridson
  1. AstraZeneca AB, Lund, Sweden (T.S., K.E., M.G., M.L., V.K., C.J., T.O., H.F.-H., H.L., A.S.); and Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada (A.C., J.L.W.)
  1. Address correspondence to:
    Dr. Harbans Lal, Clinical Early Development, Respiratory and Inflammation Therapy Area, AstraZeneca R&D Mölndal, SE-43183 Mölndal, Sweden. E-mail: harbans.lal{at}astrazeneca.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: July 2011 to March 2021

AbstractFullPdf
Jul 2011102049
Aug 20112490229
Sep 201126321115
Oct 201126940101
Nov 20111213268
Dec 2011773453
Jan 2012915491
Feb 2012574250
Mar 2012644056
Apr 2012581740
May 2012471942
Jun 2012562149
Jul 2012331036
Aug 2012622227
Sep 2012271023
Oct 2012344057
Nov 2012393731
Dec 2012293851
Jan 2013385065
Feb 2013326160
Mar 2013295160
Apr 2013264252
May 2013254939
Jun 2013285943
Jul 2013144848
Aug 201393931
Sep 2013285636
Oct 2013206378
Nov 2013166140
Dec 201343230
Jan 2014184131
Feb 2014294847
Mar 2014122815
Apr 2014206350
May 2014107641
Jun 201474433
Jul 2014193525
Aug 2014133526
Sep 2014294329
Oct 2014173019
Nov 20141712513
Dec 2014192216
Jan 2015453234
Feb 2015133613
Mar 2015244136
Apr 201582823
May 2015114033
Jun 201586742
Jul 2015133534
Aug 2015145733
Sep 2015194533
Oct 2015143841
Nov 2015103726
Dec 2015245323
Jan 2016274929
Feb 201675431
Mar 2016153535
Apr 2016183918
May 201673725
Jun 2016225167
Jul 2016304457
Aug 2016203853
Sep 2016433137
Oct 201663630
Nov 201695035
Dec 201603241
Jan 201745136
Feb 201724020
Mar 201728628
Apr 201714714
May 201743124
Jun 201713917
Jul 201713019
Aug 201744120
Sep 201743916
Oct 201754218
Nov 201725525
Dec 201713510
Jan 20182417
Feb 201844817
Mar 201862914
Apr 201824031
May 201824825
Jun 201821814
Jul 20184319
Aug 201832713
Sep 201814236
Oct 201838018
Nov 201836936
Dec 2018531010
Jan 201971313
Feb 201947513
Mar 2019261117
Apr 201948920
May 201934829
Jun 201951822
Jul 201921915
Aug 2019441422
Sep 201931621
Oct 201933514
Nov 2019361014
Dec 2019601112
Jan 20204956
Feb 2020291311
Mar 20206635
Apr 20208598
May 20203936
Jun 20203244
Jul 20202543
Aug 202064411
Sep 20203747
Oct 20202669
Nov 2020341117
Dec 20203935
Jan 202162324
Feb 2021832028
Mar 2021600

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 339 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 339, Issue 1
1 Oct 2011
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
AZD9668: Pharmacological Characterization of a Novel Oral Inhibitor of Neutrophil Elastase
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleDrug Discovery and Translational Medicine

Preclinical Pharmacology of AZD9668, a Novel NE Inhibitor

T. Stevens, K. Ekholm, M. Gränse, M. Lindahl, V. Kozma, C. Jungar, T. Ottosson, H. Falk-Håkansson, A. Churg, J. L. Wright, H. Lal and A. Sanfridson
Journal of Pharmacology and Experimental Therapeutics October 1, 2011, 339 (1) 313-320; DOI: https://doi.org/10.1124/jpet.111.182139

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleDrug Discovery and Translational Medicine

Preclinical Pharmacology of AZD9668, a Novel NE Inhibitor

T. Stevens, K. Ekholm, M. Gränse, M. Lindahl, V. Kozma, C. Jungar, T. Ottosson, H. Falk-Håkansson, A. Churg, J. L. Wright, H. Lal and A. Sanfridson
Journal of Pharmacology and Experimental Therapeutics October 1, 2011, 339 (1) 313-320; DOI: https://doi.org/10.1124/jpet.111.182139
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • C. Butyricum Alleviates bone loss after Bariatric Surgery
  • Running title: Antimuscarinic effect of mirabegron
  • Cx43 Activity and Modulation in the Myometrium
Show more Drug Discovery and Translational Medicine

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics